Skip to main content
Premium Trial:

Request an Annual Quote

NIDA Seeks Recommendations on SNPs to Develop 'Neuroarray' Platform

NEW YORK (GenomeWeb News) - The National Institute of Drug Abuse is seeking nominations for SNPs to include in a custom microarray platform it is designing to study the genetics and pharmacogenetics of drug abuse, addiction, and related mental disorders.
In a request for information released on Friday, NIDA said that it plans to develop the so-called Neuroarray “pending availability of funds,” and that it is looking for community input on “custom SNPs that provide in-depth coverage of genes with prior knowledge of association with drug addiction and related disorders.”
NIDA said it intends to make the array available competitively “through standard NIH mechanisms” to help researchers study genetic vulnerability to addiction and related disorders, and to develop genetic patient profiles for targeted pharmacotherapies.
The deadline for responses is March 30. Nominations for SNPs can be submitted here.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.